Surgery for gastric cancer chemotherapy adjuvant. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Cell Line, Tumor Gastric Mucosa Tumor Cells, Cultured Stomach Lymph Nodes Cardia

Organisms4

Mice, Nude Helicobacter pylori Mice, Inbred BALB C Mice, Inbred C57BL

Diseases54

Stomach Neoplasms Neoplasms Breast Neoplasms Adenocarcinoma Lung Neoplasms Vomiting Neoplasm Recurrence, Local Neoplasm Metastasis Nausea Ovarian Neoplasms Colonic Neoplasms Neoplasm Invasiveness Lymphatic Metastasis Carcinoma Helicobacter Infections Colorectal Neoplasms Peritoneal Neoplasms Disease Progression Prostatic Neoplasms Liver Neoplasms Postoperative Complications Neutropenia Carcinoma, Signet Ring Cell Carcinoma, Non-Small-Cell Lung Pancreatic Neoplasms Carcinoma, Squamous Cell Esophageal Neoplasms Genetic Predisposition to Disease Vomiting, Anticipatory Rectal Neoplasms Bone Neoplasms Gastritis, Atrophic Recurrence Adenocarcinoma, Scirrhous Pregnancy Complications, Neoplastic Testicular Neoplasms Mucositis Urinary Bladder Neoplasms Gastrointestinal Neoplasms Gastritis Lymphoma Neoplasms, Experimental Brain Neoplasms Metaplasia Precancerous Conditions Fatigue Uterine Cervical Neoplasms Neoplasms, Second Primary Head and Neck Neoplasms Neovascularization, Pathologic Disease Models, Animal Adenocarcinoma, Mucinous Cell Transformation, Neoplastic Neoplasms, Multiple Primary

Chemicals and Drugs67

Antineoplastic Agents Adjuvants, Immunologic Cisplatin Doxorubicin Cyclophosphamide Antineoplastic Agents, Phytogenic Paclitaxel Freund's Adjuvant Fluorouracil Antimetabolites, Antineoplastic Adjuvants, Pharmaceutic Tumor Markers, Biological Etoposide Methotrexate Taxoids Antibiotics, Antineoplastic Antiemetics Vinblastine Organoplatinum Compounds Mitomycin Deoxycytidine Neoplasm Proteins Antineoplastic Agents, Alkylating Tegafur Anthracyclines Oxonic Acid Camptothecin P-Glycoprotein RNA, Messenger Carboplatin Receptor, erbB-2 Prodrugs DNA, Neoplasm Tamoxifen Tumor Suppressor Protein p53 Cancer Vaccines Platinum RNA, Small Interfering Antineoplastic Agents, Hormonal Drug Carriers Daunorubicin Receptors, Estrogen Mitomycins Cytarabine Aniline Mustard Mitoxantrone Antibodies, Monoclonal, Humanized Antibodies, Monoclonal Pepsinogen A Granulocyte Colony-Stimulating Factor Bleomycin Enzyme Inhibitors Peptichemio Drug Combinations Ifosfamide Thymidylate Synthase Proto-Oncogene Proteins c-bcl-2 Antigens, Neoplasm Receptors, Progesterone DNA-Binding Proteins Recombinant Proteins Multidrug Resistance-Associated Proteins Carcinoembryonic Antigen Pepsinogen C Leucovorin Protein Kinase Inhibitors Cadherins

Analytical, Diagnostic and Therapeutic Techniques and Equipment86

Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Combined Modality Therapy Gastrectomy Prognosis Neoplasm Staging Survival Rate Survival Analysis Radiotherapy, Adjuvant Disease-Free Survival Follow-Up Studies Prospective Studies Drug Administration Schedule Retrospective Studies Clinical Trials as Topic Neoadjuvant Therapy Early Detection of Cancer Drug Screening Assays, Antitumor Kaplan-Meier Estimate Risk Factors Xenograft Model Antitumor Assays Immunohistochemistry Drug Delivery Systems Lymph Node Excision Multivariate Analysis Neoplasm Transplantation Reverse Transcriptase Polymerase Chain Reaction Gastroscopy Drug Therapy Molecular Targeted Therapy Risk Assessment Blotting, Western Predictive Value of Tests Drug Carriers Radiotherapy Preoperative Care Gene Expression Profiling Bariatric Surgery Administration, Oral Risk Palliative Care Odds Ratio Transplantation, Heterologous Postoperative Period Flow Cytometry Tomography, X-Ray Computed Induction Chemotherapy Tumor Burden Mastectomy Salvage Therapy Transfection Drug Evaluation Incidence Postoperative Care Neoplasms, Experimental Chemotherapy, Cancer, Regional Perfusion Sensitivity and Specificity Infusions, Intravenous Feasibility Studies Cohort Studies Registries Case-Control Studies Randomized Controlled Trials as Topic Random Allocation Proportional Hazards Models Radiotherapy Dosage Polymerase Chain Reaction Models, Biological Biopsy Patient Selection Logistic Models Inhibitory Concentration 50 Disease Models, Animal Chi-Square Distribution Analysis of Variance Immunotherapy Clinical Trials, Phase III as Topic Drug Design Immunoenzyme Techniques Questionnaires Laparoscopy Hyperthermia, Induced Cardiac Surgical Procedures Reproducibility of Results SEER Program

Phenomena and Processes33

Drug Resistance, Neoplasm Gene Expression Regulation, Neoplastic Drug Resistance, Multiple Time Factors Apoptosis Dose-Response Relationship, Drug Cell Proliferation Cell Survival Drug Synergism Genetic Predisposition to Disease Cell Cycle Mutation DNA Methylation Risk Down-Regulation Cell Division Odds Ratio Signal Transduction Transfection Genotype Sensitivity and Specificity DNA Damage Polymorphism, Genetic Drug Resistance Genes, MDR DNA Repair Gene Expression Cell Movement Inhibitory Concentration 50 Chi-Square Distribution Up-Regulation Promoter Regions, Genetic Base Sequence

Disciplines and Occupations5

Immunohistochemistry Medical Oncology General Surgery Thoracic Surgery Drug Design

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries Molecular Sequence Data Base Sequence Questionnaires SEER Program

Named Groups1

Health Care37

Treatment Outcome Survival Rate Survival Analysis Disease-Free Survival Follow-Up Studies Prospective Studies Retrospective Studies Clinical Trials as Topic Kaplan-Meier Estimate Risk Factors Multivariate Analysis Risk Assessment Age Factors Predictive Value of Tests Preoperative Care Risk Palliative Care Odds Ratio Postoperative Period Incidence Postoperative Care Sensitivity and Specificity Feasibility Studies Cohort Studies Registries Case-Control Studies Randomized Controlled Trials as Topic Random Allocation Proportional Hazards Models Patient Selection Logistic Models Chi-Square Distribution Analysis of Variance Clinical Trials, Phase III as Topic Questionnaires Reproducibility of Results SEER Program

Geographicals3

Japan China United States

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Health Care Geographicals

Stomach Neoplasms Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Adjuvants, Immunologic Neoplasms Cisplatin Treatment Outcome Breast Neoplasms Combined Modality Therapy Gastrectomy Doxorubicin Prognosis Neoplasm Staging Drug Resistance, Neoplasm Adenocarcinoma Cell Line, Tumor Cyclophosphamide Lung Neoplasms Survival Rate Survival Analysis Radiotherapy, Adjuvant Disease-Free Survival Antineoplastic Agents, Phytogenic Paclitaxel Vomiting Freund's Adjuvant Gene Expression Regulation, Neoplastic Fluorouracil Follow-Up Studies Antimetabolites, Antineoplastic Adjuvants, Pharmaceutic Neoplasm Recurrence, Local Neoplasm Metastasis Drug Resistance, Multiple Time Factors Prospective Studies Drug Administration Schedule Nausea Ovarian Neoplasms Tumor Markers, Biological Etoposide Methotrexate Taxoids Antibiotics, Antineoplastic Colonic Neoplasms Retrospective Studies Antiemetics Mice, Nude Neoplasm Invasiveness Apoptosis Helicobacter pylori Clinical Trials as Topic Neoadjuvant Therapy Vinblastine Organoplatinum Compounds Early Detection of Cancer Lymphatic Metastasis Carcinoma Gastric Mucosa Helicobacter Infections Dose-Response Relationship, Drug Colorectal Neoplasms Mitomycin Deoxycytidine Neoplasm Proteins Drug Screening Assays, Antitumor Peritoneal Neoplasms Kaplan-Meier Estimate Tumor Cells, Cultured Antineoplastic Agents, Alkylating Cell Proliferation Risk Factors Tegafur Anthracyclines Xenograft Model Antitumor Assays Oxonic Acid Camptothecin Disease Progression Cell Survival Prostatic Neoplasms Liver Neoplasms P-Glycoprotein Immunohistochemistry Postoperative Complications Neutropenia Carcinoma, Signet Ring Cell Drug Delivery Systems Lymph Node Excision RNA, Messenger Carcinoma, Non-Small-Cell Lung Multivariate Analysis Neoplasm Transplantation Pancreatic Neoplasms Mice, Inbred BALB C Reverse Transcriptase Polymerase Chain Reaction Drug Synergism Japan Quality of Life Carboplatin

No FAQ available that match "surgery for gastric cancer chemotherapy adjuvant"